Home > Insider Trading > Filing (0001827672-23-000045)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819790	Tarsus Pharmaceuticals Inc.	TARS	Biological Products, (No Disgnostic Substances) (2836)	814717861

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1827672	R. Bobak Azamian	C/O Tarsus Pharmaceuticals, Inc. 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618	President/Ceo And Board Chair	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-11-15	2,896	$18.01	883,210	No	4	S	Indirect	By the Bobak Azamian Living Trust established April 16, 2018
Common Stock	Disposition	2023-11-15	4,904	$18.54	878,306	No	4	S	Indirect	By the Bobak Azamian Living Trust established April 16, 2018
Common Stock	Disposition	2023-11-15	200	$19.28	878,106	No	4	S	Indirect	By the Bobak Azamian Living Trust established April 16, 2018

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By the Bobak Azamian Living Trust established April 16, 2018
No	4	S	Indirect	By the Bobak Azamian Living Trust established April 16, 2018
No	4	S	Indirect	By the Bobak Azamian Living Trust established April 16, 2018

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,597	Direct

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023.
The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.25 to $18.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.
The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.27 to $19.21. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.